In vitro chemosensitization of Plasmodium falciparum to antimalarials by verapamil and probenecid

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 7, 2009, Pages 3131-3134

  Masseno, Victor ^a   Muriithi, Steven ^a   Nzila, Alexis ^a,b  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOQUINOLINE DERIVATIVE; AMODIAQUINE; BENFLUMETOL; CHLORCYCLOGUANIL; CHLOROQUINE; DEETHYLAMODIAQUINE; DIHYDROARTEMISININ; HALOFANTRINE; MEFLOQUINE; METHOTREXATE; PIPERAQUINE; PRIMAQUINE; PROBENECID; PYRIMETHAMINE; PYRONARIDINE; QUININE; VERAPAMIL;

ARTICLE; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; IN VITRO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PARASITE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADJUVANTS, PHARMACEUTIC; ANIMALS; ANTIMALARIALS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PROBENECID; VERAPAMIL;

EID: 67649975606     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01689-08     Document Type: Article

References (28)

1. Adovelande, J., J. Deleze, and J. Schrevel. 1998. Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum. Biochem. Pharmacol. 55:433-440.
2. Berenbaum, M. C. 1978. A method for testing for synergy with any number of agents. J. Infect. Dis. 137:122-130.
3. Brogden, R. N., and P. Benfield. 1996. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease. Drugs 51:792-819.
4. Ciach, M., K. Zong, K. C. Kain, and I. Crandall. 2003. Reversal of mefloquine and quinine resistance in Plasmodium falciparum with NP30. Antimicrob. Agents Chemother. 47:2393-2396.
5. Echeverry, D. F., G. Holmgren, C. Murillo, J. C. Higuita, A. Bjorkman, J. P. Gil, and L. Osorio. 2007. Short report: polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine. Am. J. Trop. Med. Hyg. 77:1034-1038.
6. Egan, T. J., and C. H. Kaschula. 2007. Strategies to reverse drug resistance in malaria. Curr. Opin. Infect. Dis. 20:598-604.
7. Ekland, E. H., and D. A. Fidock. 2007. Advances in understanding the genetic basis of antimalarial drug resistance. Curr. Opin. Microbiol. 10:363-370.
8. Henry, M., S. Alibert, E. Orlandi-Pradines, H. Bogreau, T. Fusai, C. Rogier, J. Barbe, and B. Pradines. 2006. Chloroquine resistance reversal agents as promising antimalarial drugs. Curr. Drug Targets 7:935-948.
9. Johnson, D. J., D. A. Fidock, M. Mungthin, V. Lakshmanan, A. B. Sidhu, P. G. Bray, and S. A. Ward. 2004. Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol. Cell 15:867-877.
10. Kelly, J. X., M. J. Smilkstein, R. A. Cooper, K. D. Lane, R. A. Johnson, A. Janowsky, R. A. Dodean, D. J. Hinrichs, R. Winter, and M. Riscoe. 2007. Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum. Antimicrob. Agents Chemother. 51:4133-4140.
11. Lehane, A. M., R. Hayward, K. J. Saliba, and K. Kirk. 2008. A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites. J. Cell Sci. 121:1624-1632.
12. Martin, S. K., A. M. Oduola, and W. K. Milhous. 1987. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235:899-901.
13. Martiney, J. A., A. Cerami, and A. F. Slater. 1995. Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect. J. Biol. Chem. 270:22393-22398.
14. McTavish, D., and E. M. Sorkin. 1989. Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. Drugs 38:19-76.
15. Min, T. H., M. F. Khairul, J. H. Low, C. H. Che Nasriyyah, A. N. A'Shikin, M. N. Norazmi, M. Ravichandran, and S. S. Raju. 2007. Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro. Exp. Parasitol. 115:387-392.
16. Nduati, E., A. Diriye, S. Ommeh, L. Mwai, S. Kiara, V. Masseno, G. Kokwaro, and A. Nzila. 2008. Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer. Parasitol. Res. 102:1227-1234.
17. Nosten, F., and N. J. White. 2007. Artemisinin-based combination treatment of falciparum malaria. Am. J. Trop. Med. Hyg. 77:181-192.
18. Nzila, A., E. Mberu, P. Bray, G. Kokwaro, P. Winstanley, K. Marsh, and S. Ward. 2003. Chemosensitization of Plasmodium falciparum by probenecid in vitro. Antimicrob. Agents Chemother. 47:2108-2112.
19. Ommeh, S., E. Nduati, E. Mberu, G. Kokwaro, K. Marsh, A. Rosowsky, and A. Nzila. 2004. In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum. Antimicrob. Agents Chemother. 48:3711-3714.
20. Sidhu, A. B., D. Verdier-Pinard, and D. A. Fidock. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210-213.
21. Sowunmi, A., A. A. Adedeji, B. A. Fateye, and F. A. Fehintola. 2004. Comparative effects of pyrimethamine-sulfadoxine, with and without probenecid, on Plasmodium falciparum gametocytes in children with acute, uncomplicated malaria. Ann. Trop. Med. Parasitol. 98:873-878.
22. Sowunmi, A., F. A. Fehintola, A. A. Adedeji, A. G. Falade, C. O. Falade, O. O. Akinyinka, and A. M. Oduola. 2000. Comparative efficacy of chloroquine plus chlorpheniramine alone and in a sequential combination with sulfadoxine-pyrimethamine, for the treatment of acute, uncomplicated, falciparum malaria in children. Ann. Trop. Med. Parasitol. 94:209-217.
23. Sowunmi, A., F. A. Fehintola, A. A. Adedeji, G. O. Gbotosho, C. O. Falade, E. Tambo, B. A. Fateye, T. C. Happi, and A. M. Oduola. 2004. Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children. Trop. Med. Int. Health 9:606-614.
24. Sowunmi, A., F. A. Fehintola, O. A. Ogundahunsi, and A. M. Oduola. 1998. Comparative efficacy of chloroquine plus chlorpheniramine and halofantrine in acute uncomplicated falciparum malaria in Nigerian children. Trans. R. Soc. Trop. Med. Hyg. 92:441-445.
25. Sowunmi, A., G. O. Gbotosho, C. T. Happi, A. A. Adedeji, O. M. Bolaji, F. A. Fehintola, B. A. Fateye, and A. M. Oduola. 2007. Enhancement of the antimalarial efficacy of amodiaquine by chlorpheniramine in vivo. Mem. Inst. Oswaldo Cruz 102:417-419.
26. Sowunmi, A., A. M. Oduola, O. A. Ogundahunsi, and L. A. Salako. 1998. Enhancement of the antimalarial effect of chloroquine by chloropheniramine in vivo. Trop. Med. Int. Health 3:177-183.
27. Valderramos, S. G., and D. A. Fidock. 2006. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol. Sci. 27:594-601.
28. van Schalkwyk, D. A., J. C. Walden, and P. J. Smith. 2001. Reversal of chloroquine resistance in Plasmodium falciparum using combinations of chemosensitizers. Antimicrob. Agents Chemother. 45:3171-3174.